FOXM1 and small cell lung carcinoma: Based on the FOXM1 expression and KD data that suggested FOXM1 as a potential therapeutic target, we evaluated the efficacy of selective FOXM1 inhibitors (FOXM1i) available, including FDI-6 and NB-73, for FOXM1 targeting in SCLC [31, 33].